Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Stomach cancer patients to be denied drug after new NICE guidance

  • 1 Comment

New guidance could prevent patients with a rare form of stomach cancer being prescribed a drug on the NHS, which campaigners say would be 'a devastating blow'.

NICE has ruled that the drug Sutent, which is prescribed for advanced tumours, should not be given to patients with advanced gastrointestinal stromal tumour (GIST) after apparently questioning the way clinical trial data was analysed in a submission from Sutent's manufacturer, Pfizer.

Around 900 people are newly-diagnosed with the cancer, which affects the soft tissue surrounding the digestive tract, each year, and it is thought that 1,500 people are living with the advanced form of the terminal cancer.

However, NICE has recommended that Sutent, which is also called sunitinib, should not be given as a second-line treatment for people with advanced GIST, which one oncologist says will 'deny patients the chance of extended good quality life'.

Dr Beatrice Seddon, consultant clinical oncologist at University College London Hospital, said that Sutent is given to patients who had stopped responding to another GIST drug, Glivec, also known as imatinib.

'This is a devastating blow to the GIST community,' she said. 'We know that patients will eventually stop responding to imatinib, and then sunitinib is their only option for further treatment.'

  • 1 Comment

Readers' comments (1)

  • I feel evryone shoul be given a chance for a longer quality of life unless it is the individuals choice not to,thereby hope NICE will do this favour for all who needs it and hpefully one will reverse their decesion.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.